MedTrace Logo

Mediterranean Diet as an add-on Therapy for Induction of Remission in Patients With Active Crohn's Disease

NCT02825316 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-07-07

No results posted yet for this study

Summary

This clinical study is designed to evaluate the effect of Mediterranean diet as an add-on therapy for induction of remission in adult patients with active Crohn's disease and to evaluate its effects on clinical, inflammatory and microbial parameters.

Conditions

Interventions

BEHAVIORAL

Mediterranean diet

Eight weeks course of Mediterranean diet (rich in plant-based food and low in animal protein and fat).

BEHAVIORAL

Low residue diet

Eight weeks course of low residue diet (minimal consumption of foods that add residue to the stool, such as raw fruits, vegetables and seeds, as well as nuts, legumes and whole grains).

Sponsors & Collaborators

  • michal roll

    lead OTHER_GOV

Principal Investigators

  • Iris Dotan, MD · Head, IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Sourasky Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-01-31
Completion
2019-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02825316 on ClinicalTrials.gov